Report Initial Data News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Report Initial Data. Real-time updates on events, politics, business and more.

Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

August 3, 2023

- On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Half of 2023 - WALTHAM, Mass., Aug. 03, 2023 --...

Amy Reilly Stacy Nartker Joshua Brumm Exchange Commission European Medicines Agency Dyne Therapeutics Inc

Source: marketscreener.com

Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

May 11, 2023

- On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Half of 2023 - WALTHAM, Mass., May 11, 2023 -- Dyne... | May 11, 2023

United States Joshua Brumm Los Angeles Amy Reilly Muscular Dystrophy Association Drug Administration

Source: marketscreener.com

Design Therapeutics Inc Stock Quote | Stock Price for DSGN | FinancialContent Business Page

October 17, 2022

FinancialContent fully hosted finance channel

Company On Track Report Initial Data Friedreich Ataxia Phase Fourth Quarter

Source: financialcontent.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Report Initial Data News Today

Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

Design Therapeutics Inc Stock Quote | Stock Price for DSGN | FinancialContent Business Page

Explore More Categories